Industry News

PPD’s Randy Anderson named Health Care Hero for diabetes research

Centerwatch - Thu, 2014-11-20 07:49
Randy Anderson, Ph.D., vice president of global product development and therapeutic area leader for metabolics at global CRO Pharmaceutical Product Development (PPD), was named a 2014 Health Care Hero. The annual awards honor members of the greater Wilmington medical community for their engagement on critical health issues.
Categories: Industry News

Vermillion forms new strategic and medical advisory board

Centerwatch - Thu, 2014-11-20 07:43
Vermillion, a bio-analytical solutions company focused on gynecologic disease, recently outlined its expanded strategy for driving improvements in the personalized management of gynecologic health and becoming a leading diagnostic innovator in gynecologic informatics. In support of this mission, the company has named three charter members of its strategic and medical advisory board.
Categories: Industry News

Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities

sleep - Wed, 2014-11-19 19:00
Status: Recruiting, Condition Summary: Sleep Disorders
Categories: Industry News

Drugs@FDA Data Files

FDA News - Wed, 2014-11-19 15:32
Data files updated through November 12, 2014.
Categories: Industry News

Amgen, Novartis partner with Atlas Venture

Centerwatch - Wed, 2014-11-19 09:37
Atlas Venture, based in Cambridge, Mass., has entered into corporate strategic partnership (CSP) agreements with both Amgen, through its venture capital fund, Amgen Ventures, and Novartis. Atlas IX is expected to create and/or fund more than 15 new biotech companies and anticipates these new CSP relationships will be integral parts of facilitating their launch and progression.    
Categories: Industry News

Amgen , Novartis partner with Atlas Venture

Centerwatch - Wed, 2014-11-19 09:37
Atlas Venture, based in Cambridge, Mass., has entered into corporate strategic partnership (CSP) agreements with both Amgen, through its venture capital fund, Amgen Ventures, and Novartis. Atlas IX is expected to create and/or fund more than 15 new biotech companies and anticipates these new CSP relationships will be integral parts of facilitating their launch and progression.    
Categories: Industry News

Certara updates Simcyp Simulator

Centerwatch - Wed, 2014-11-19 09:36
Certara, a Princeton, N.J.-based global technology-enabled drug development and drug safety consultancy, has released version 14 of its Simcyp Population-based Simulator, which enables biopharmaceutical researchers to predict drug-drug interactions and pharmacokinetic-pharmacodynamic (PK-PD) outcomes in virtual human and animal populations.
Categories: Industry News

Genomics England calls on the U.K. research community

Centerwatch - Wed, 2014-11-19 09:25
Genomics England is inviting applications to join a new Clinical Interpretation Partnership from U.K. researchers, NHS Clinicians and those in training where they will work on the unique data resource from the 100,000 Genomes Project. The goal of the Genomics England Clinical Interpretation Partnership (GeCIP) is to bring together the best researchers in the U.K., alongside their key international collaborators, to ensure maximized potential to gaining new biological insights into rare inherited diseases, cancers and infectious disease.
Categories: Industry News

Veeva Systems launches Veeva CRM CoBrowse

Centerwatch - Wed, 2014-11-19 09:25
Veeva Systems, a cloud-based technology company based in Pleasanton, Calif., has launched Veeva CRM CoBrowse, a new remote detailing solution that enables real-time, interactive engagement and collaboration with customers online. CoBrowse allows call center, medical affairs and field sales teams to lead healthcare professionals (HCPs) through approved promotional and medical content, while automatically capturing all interaction details in Veeva CRM. It also can leverage Veeva Closed Loop Marketing (CLM) content to maximize message consistency and return on content investment across channels.
Categories: Industry News

USAID, Broad Institute, Illumina partner in West Africa for Ebola

Centerwatch - Wed, 2014-11-19 09:22
To help combat the Ebola epidemic in West Africa, the U.S. Agency for International Development (USAID), the Massachusetts-based Broad Institute of MIT and Harvard and San Diego, Calif.-based Illumina have entered into a public-private partnership.
Categories: Industry News

goBalto launches Analyze to advance clinical study start-up reporting

Centerwatch - Wed, 2014-11-19 09:22
goBalto, a San Francisco-based provider of cloud-based clinical study startup solutions, has released Analyze, a reporting tool that provides a real-time view into clinical operations data.
Categories: Industry News

Neuro-MAP, MRC Technology to jumpstart drug development for brain diseases

Centerwatch - Wed, 2014-11-19 09:18
Drugs for brain diseases such as dementia, motor neurone disease and Parkinson’s, which have stalled in development, could be revived thanks to up to $47.1 million in funding and resources from a global coalition of charities and funders. The Neurodegeneration Medicines Acceleration Program (Neuro-MAP), led by U.K. medical research charity MRC Technology, will help charities and funding bodies identify promising drug projects no longer in development and help scientists take them forward to the next stage.
Categories: Industry News

IBM Watson Group invests in Pathway Genomics to help personalize consumer health

Centerwatch - Wed, 2014-11-19 09:15
IBM Watson Group has invested in Pathway Genomics, a San Diego-based clinical laboratory that offers genetic testing services globally, to help deliver the first-ever cognitive consumer-facing app based on genetics from a user's personal makeup.
Categories: Industry News

Ricerca Biosciences acquired by equity investment group Main Market Partners

Centerwatch - Wed, 2014-11-19 09:14
Ricerca Biosciences, based in Ohio, has been acquired by Main Market Partners, a middle-market growth investment fund in the same region. Terms of the sale have not been disclosed.
Categories: Industry News

Veeva Systems updates Veeva Vault

Centerwatch - Wed, 2014-11-19 09:13
Veeva Systems, based in Pleasanton, Calif., has released Veeva Vault innovations. Individuals across the organization can share and reuse approved content, eliminating manual hand-offs and duplicate work. At the same time, Vault provides local autonomy and flexibility for each department or region to manage its own content to reflect its unique business processes. Vault maintains one authoritative source document in the cloud to bridge content gaps, increasing efficiency, visibility and compliance. 
Categories: Industry News

Current Projects

FDA News - Tue, 2014-11-18 14:03
Part of Safe Use Initiative (updated)
Categories: Industry News

Tufts CSDD: Developing, winning marketing approval for a new drug now cost $2.6 billion

Centerwatch - Tue, 2014-11-18 09:22
Developing and gaining marketing approval for a new prescription medicine, a process often lasting longer than a decade, is estimated to cost $2,558 million, according to a new study by the Tufts Center for the Study of Drug Development (CSDD).
Categories: Industry News

Esomeprazole Plus Alginate vs. Esomeprazole Alone for Treatment of Nighttime Reflux Symptom and Sleep Disturbances

sleep - Mon, 2014-11-17 19:00
Status: Recruiting, Condition Summary: Gastroesophageal Reflux Disease; Heartburn; Sleep Disturbance
Categories: Industry News

Additions/Deletions for Prescription and OTC Drug Product Lists

FDA News - Mon, 2014-11-17 12:55
The list has been updated through October 2014.
Categories: Industry News

Geron, Janssen collaborate to develop and commercialize imetelstat

Centerwatch - Mon, 2014-11-17 09:36
Geron, a Menlo Park, Calif.-based clinical stage biopharmaceutical company, has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech to develop and commercialize imetelstat, Geron`s telomerase inhibitor product candidate, for oncology, including hematologic malignancies and other human therapeutics uses.
Categories: Industry News
Syndicate content